{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:25:59Z","timestamp":1792621559897,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.diagmicrobio.2003.11.007","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T10:36:08Z","timestamp":1084271768000},"page":"41-46","source":"Crossref","is-referenced-by-count":66,"title":["In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-esbl producing klebsiella pneumoniae"],"prefix":"10.1016","volume":"49","author":[{"given":"David S","family":"Burgess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Ronald G","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1198-743x.2001.x","article-title":"Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum \u03b2-lactmases","volume":"7","author":"Bedenic","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB3","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1592\/phco.23.12.1232.32706","article-title":"Clinical and microbiological analysis of a hospital's extended spectrum beta-lactamase producing isolates over a 2 year period","volume":"23","author":"Burgess","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB4","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0149-2918(02)80021-2","article-title":"Pharmacokinetics and pharmacodynamics of piperacillin\/tazobactam by continuous infusion and intermittent dosing","volume":"24","author":"Burgess","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0149-2918(00)87978-3","article-title":"Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion","volume":"22","author":"Burgess","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.26.5.715","article-title":"Multiple-dose pharmacokinetics of imipenem-cilastatin","volume":"26","author":"Drusano","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000239575","article-title":"In vitro time-kill curves of cefepime and cefpirome combined with amikacin, gentamicin or ciprofloxacin against Klebsiella pneumoniae producing extended-spectrum beta-lactamase","volume":"43","author":"Elkhaili","year":"1997","journal-title":"Chemotherapy"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/AAC.34.5.858","article-title":"Activities of \u03b2-lactam antibiotics against Escheichia coli strains producing extended-spectrum \u03b2-lactamases","volume":"34","author":"Jacoby","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB9","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1128\/AAC.39.5.1187","article-title":"In vitro activities of various \u03b2-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp resistant to oxyimino cephalosporins","volume":"39","author":"Jett","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0732-8893(02)00358-9","article-title":"Potency and antimicrobial spectrum update for piperacillin\/tazobactam (2000)","volume":"43","author":"Johnson","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/AAC.38.2.195","article-title":"Different ratios of piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum \u03b2-lactamase","volume":"38","author":"Leleu","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB12","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1128\/AAC.36.12.2794","article-title":"Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects in patients with renal impairment","volume":"36","author":"Leroy","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1128\/AAC.36.9.1883","article-title":"Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-prodcuing strain of Klebsiella pneumoniae or its susceptible variant","volume":"36","author":"Mentec","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1592\/phco.21.11.920.34529","article-title":"Extended-spectrum \u03b2-lactamases","volume":"21","author":"Nathisuwan","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB15","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS) (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th Ed. Approved Standard Document M7-A5. Wayne, PA: NCCLS"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/00001432-200112000-00006","article-title":"Extended-spectrum beta-lactamases","volume":"14","author":"Paterson","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1046\/j.1469-0691.2000.00107.x","article-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)","volume":"6","author":"Paterson","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/517217","article-title":"Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli","volume":"28","author":"Paterson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342577","article-title":"Molecular epidemiology of a citywide outbreak of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae infection","volume":"35","author":"Quale","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/46.3.461","article-title":"In vitro activities of parenteral \u03b2-lactam antimicrobials against TEM-10-, TEM-26- and SHV-5-derived extended-spectrum \u03b2-lactamases expressed in an isogenic Escherichia coli host","volume":"46","author":"Rebuck","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB21","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/AAC.38.11.2663","article-title":"In vivo efficacies of \u03b2-lactam-\u03b2-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae","volume":"38","author":"Rice","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0732-8893(02)00469-8","article-title":"Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers","volume":"44","author":"Sader","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.46.1.196-202.2002","article-title":"Occurrence of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae in Italy","volume":"46","author":"Spanu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB24","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.45.4.1287-1291.2001","article-title":"In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae strain","volume":"45","author":"Szabo","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/AAC.41.5.1053","article-title":"Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended spectrum \u03b2-lactamase-producing strain of Klebsiella pneumoniae","volume":"41","author":"Thauvin-Eliopoulos","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB26","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1592\/phco.21.6.583.34537","article-title":"Therapeutic challenges associated with extended-spectrum, \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"21","author":"Wong-Beringer","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2003.11.007_BIB29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jac\/21.1.138","article-title":"Effect of antibiotic carry-over on bacterial counting by \u201cspiral plating\u201d","volume":"21","author":"Yorassowsky","year":"1988","journal-title":"J Antimicrob Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889303002505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:39:02Z","timestamp":1585798742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889303002505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0732889303002505"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2003.11.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}